A

nd so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Our agenda kicks off with another installment in our “let’s-see-them-before-they-die” concert series, but then is likely to ease into a series of overdue naps. And what about you? There is a holiday approaching on this side of the pond, so perhaps this is a chance to plan your menu or determine how to decline an unwanted invitation. You could enjoy the great outdoors. Or simply do nothing. Well, whatever your choices, have a grand time. But be safe. Enjoy, and see you soon …

Bratislava, Slovakia, and Milan, Italy, have emerged as front-runners to host the European Medicines Agency after Brexit, the Financial Times informs us. European Union ministers from 27 countries will vote in a secret ballot on Nov. 20 on a new home for the regulator. However, an EMA survey of employees found that more than 70 percent of its staff may leave if the agency is moved to the Slovak capital.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy